Gastrins and Gastrinomas
Overview
Overview
Journal
Postgrad Med J
Publisher
Oxford University Press
Specialty
General Medicine
Date
1984 Nov 1
PMID
6390404
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The past 20 years have seen gastrin attain true hormonal status. Its structure has been characterized, it has been synthesized, radioimmunoassays for its measurement in blood and tissues have been developed and its physiology and metabolism elucidated. Of much interest to clinicians has been the association between gastrin and tumours of the pancreas (gastrinomas) and atrophic gastritis. The advent of gastrin measurement has facilitated the diagnosis of gastrinoma and the availability of powerful acid suppressants has altered the therapy of gastrinoma.
References
1.
STRICKLAND R, Korman M, Hansky J
. Gastrin, age and the gastric mucosa. Aust N Z J Med. 1973; 3(2):152-6.
DOI: 10.1111/j.1445-5994.1973.tb03968.x.
View
2.
Richardson C, Feldman M, MCCLELLAND R, Dickerman R, Kumpuris D, Fordtran J
. Effect of vagotomy in Zollinger-Ellison syndrome. Gastroenterology. 1979; 77(4 Pt 1):682-6.
View
3.
GREGORY R, TRACY H
. The preparation and properties of gastrin. J Physiol. 1961; 156:523-43.
PMC: 1359901.
DOI: 10.1113/jphysiol.1961.sp006691.
View
4.
STRAUS E, Gerson C, Yalow R
. Hypersecretion of gastrin associated with the short bowel syndrome. Gastroenterology. 1974; 66(2):175-80.
View
5.
Rehfeld J, Stadil F, Vikelsoe J
. Immunoreactive gastrin components in human serum. Gut. 1974; 15(2):102-11.
PMC: 1412905.
DOI: 10.1136/gut.15.2.102.
View